Search results for "Respiratory system"

showing 10 items of 1829 documents

New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension deliver…

2018

COPD causes considerable health and economic burden worldwide, with incidence of the disease expected to continue to rise. Inhaled bronchodilators, such as long-acting muscarinic antagonists (LAMAs) and long-acting β2-agonists (LABAs), are central to the maintenance treatment of patients with COPD. Clinical studies have demonstrated that combined LAMA + LABA therapies improve efficacy while retaining a safety profile similar to LAMA or LABA alone. This has led to the development of several LAMA/LABA fixed-dose combination (FDC) therapies, which provide patients with the convenience of two active compounds in a single inhaler. GFF MDI (Bevespi Aerosphere®) is an FDC of glycopyrrolate/formote…

medicine.medical_specialtymedicine.drug_classDrug CompoundingFixed-dose combinationMuscarinic AntagonistsPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineFormoterol FumarateBronchodilatorAdministration InhalationmedicineHumans030212 general & internal medicineIntensive care medicineAdrenergic beta-2 Receptor AgonistsGlycopyrrolateCOPDbiologybusiness.industryInhalerGeneral MedicineLamamedicine.diseasebiology.organism_classificationGlycopyrrolateMetered-dose inhalerBronchodilator AgentsDrug CombinationsTreatment Outcome030228 respiratory systemFormoterolbusinesshormones hormone substitutes and hormone antagonistsmedicine.drugInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Asthma-COPD overlap syndrome: recent advances in diagnostic criteria and prognostic significance.

2017

The term asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) has been proposed for individuals with features of both asthma and COPD. Several attempts have been done to define ACOS on the basis of medical history, symptoms, and functional findings. The main diagnostic criteria include airflow obstruction with a strong although incomplete reversibility to bronchodilation tests, a significant exposure to cigarette or biomass smoke, and a history of atopy or asthma. Additional diagnostic elements include eosinophilic airway and systemic inflammation, a good response to corticosteroid treatment, and a high concentration of exhaled nitric oxide. ACOS should be distinguish…

medicine.medical_specialtymedicine.drug_classPrognosiComorbidity030204 cardiovascular system & hematologySettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineRisk FactorsInternal medicineBronchodilatorMedicineHumansMedical historyFunctional abilityAsthmaCOPDbusiness.industryRisk FactorMedicine (all)SmokingOverlap syndromeGeneral Medicinemedicine.diseasePrognosisComorbidityAsthmarespiratory tract diseases030228 respiratory systemExhaled nitric oxidebusinessHumanMinerva medica
researchProduct

Airway Deposition of Extrafine Inhaled Triple Therapy in Patients with COPD: A Model Approach Based on Functional Respiratory Imaging Computer Simula…

2020

Omar S Usmani,1 Nicola Scichilone,2 Benjamin Mignot,3 Dennis Belmans,3 Cedric Van Holsbeke,3 Jan De Backer,3 Roberta De Maria,4 Erika Cuoghi,4 Eva Topole,4 George Georges4 1Airway Disease Section, National Heart and Lung Institute, Imperial College, London, UK; 2PROMISE Department of Medicine, University of Palermo, Palermo, Italy; 3FLUIDDA, Kontich, Belgium; 4Chiesi Farmaceutici, SpA, Parma, ItalyCorrespondence: George GeorgesChiesi USA Inc., 175 Regency Woods Place, Ste. 600, Cary, NC 27518, USATel +1 (919) 678 6611 x1536Email george.georges@chiesi.comIntroduction: There is a clear correlation between small airways dysfunction and poor clinical outcomes in patients with chronic obstructiv…

medicine.medical_specialtymedicine.drug_classRespiratory SystemUrologyInternational Journal of Chronic Obstructive Pulmonary DiseaseSettore MED/10 - Malattie Dell'Apparato RespiratoriotomographyDry powder inhalers Inhaled corticosteroid Long-acting beta2 agonist Long-acting muscarinic antagonist Metered dose inhalers Tomography X-ray computedinhaled corticosteroidFluticasone propionatePulmonary Disease Chronic Obstructivechemistry.chemical_compoundFormoterol FumarateBronchodilatorAdministration InhalationmedicineHumanslong-acting muscarinic antagonistComputer SimulationGlycopyrronium bromideRespiratory systemmetered dose inhalers1102 Cardiorespiratory Medicine and HaematologyOriginal Researchx-ray computedlcsh:RC705-779COPDScience & TechnologyInhalationbusiness.industrydry powder inhalersGeneral Medicinelcsh:Diseases of the respiratory systemrespiratory systemmedicine.diseaseBronchodilator AgentsDrug CombinationschemistryCorticosteroidVilanterolbusinessLife Sciences & Biomedicinelong-acting beta2 agonistmedicine.drugInternational Journal of COPD
researchProduct

Physiopathological rationale of using high-flow nasal therapy in the acute and chronic setting: A narrative review

2019

Abstract Chronic lung disease and admissions due to acute respiratory failure (ARF) are becoming increasingly common. Consequently, there is a growing focus on optimizing respiratory support, particularly non-invasive respiratory support, to manage these conditions. High flow nasal therapy (HFNT) is a noninvasive technique where humidified and heated gas is delivered through the nose to the airways via small dedicated nasal prongs at flows that are higher than the rates usually applied during conventional oxygen therapy. HFNT enables to deliver different inspired oxygen fractions ranging from 0.21 to 1. Despite having only recently become available, the use of HFNT in the adult population i…

medicine.medical_specialtymedicine.medical_treatmentCritical Care and Intensive Care MedicineAcute respiratory failure03 medical and health sciences0302 clinical medicine030202 anesthesiologyOxygen therapyMedicineAcute respiratory failureRespiratory systemIntensive care medicineNoseHigh flow nasal therapybusiness.industryChronic obstructive pulmonary disease030208 emergency & critical care medicineHigh flow nasal cannulaAnesthesiology and Pain Medicinemedicine.anatomical_structureRespiratory failureLung diseaseNarrative reviewbusinessHigh flowNoninvasive ventilation
researchProduct

Analysis and evaluation of periodic physiological organ motion in radiotherapy treatments.

2003

Background and purpose: A system for the detection, measurement and analysis of the periodic physiological organ motion during radiotherapy treatment is proposed and clinically tested in this paper. Material and methods: The procedure is based on the acquisition of fluoroscopic sequences, followed by an automatic detection of the movement using cross-correlations with matched filters. Results: The system generates a probability density function (PDF) of finding a mobile organ in a position at a certain time. The maximum path of the mobile structures can be determined to define the planning target volume (PTV) without ambiguities. Conclusions: Physiological movements can be accurately includ…

medicine.medical_specialtymedicine.medical_treatmentMovementRespiratory SystemPlanning target volumeProbability density functionPatient Care PlanningAutomationOrgan MotionPosition (vector)NeoplasmsMedicineHumansRadiology Nuclear Medicine and imagingComputer visionbusiness.industryMatched filterRespirationHematologySurgeryRadiation therapyOncologyFluoroscopyRadiotherapy treatmentArtificial intelligenceDose Fractionation RadiationRadiotherapy ConformalbusinessRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
researchProduct

Managing Persistent Hypoxemia: what is new?

2017

Mechanical ventilation is the standard life-support technique for patients with severe acute respiratory failure. However, some patients develop persistent and refractory hypoxemia because their lungs are so severely damaged that they are unable to respond to the application of high inspired oxygen concentration and high levels of positive end-expiratory pressure. In this article, we review current knowledge on managing persistent hypoxemia in patients with injured lungs.

medicine.medical_specialtymedicine.medical_treatmentPhysiologyReviewmechanical ventilationGeneral Biochemistry Genetics and Molecular BiologyHypoxemia03 medical and health sciences0302 clinical medicineRefractorysevere acute respiratory failuremedicineAcute respiratory failureIn patientGeneral Pharmacology Toxicology and PharmaceuticsIntensive care medicineMechanical ventilationInspired oxygen concentrationhypoxemiaGeneral Immunology and Microbiologypersistent hypoxemiabusiness.industry030208 emergency & critical care medicineGeneral MedicineArticlesrespiratory tract diseases030228 respiratory systemRespiratory Problems in Critical Caremedicine.symptombusinessF1000Research
researchProduct

Xerostomia in patients with sleep apnea-hypopnea syndrome : a prospective case-control study

2020

Background To describe the characteristics of xerostomia (dry mouth) in the population with sleep apnea-hypopnea syndrome (SAHS) and contrast its prevalence versus that found in healthy subjects, and to compare the frequency of xerostomia in SAHS patients with and without continuous positive airway pressure (CPAP) treatment. Material and methods A prospective comparative study was made between adults recently diagnosed with SAHS in a public hospital (n=60) and healthy individuals (n=54). The presence of xerostomia was assessed on waking up and during the day, using a frequency scale from 0 ("never") to 3 ("always"). Results The prevalence of xerostomia on waking up in the SAHS group was 45%…

medicine.medical_specialtymedicine.medical_treatmentPopulation03 medical and health sciences0302 clinical medicinestomatognathic systemInternal medicinemedicineIn patientContinuous positive airway pressurecardiovascular diseaseseducationGeneral Dentistryeducation.field_of_studybusiness.industryResearchCase-control studySleep apnea030206 dentistryDry mouthmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Obesitynervous system diseasesstomatognathic diseases030228 respiratory systemUNESCO::CIENCIAS MÉDICASOdontostomatology for the Disabled or Special Patientsmedicine.symptombusinessBody mass index
researchProduct

Official Statement of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) on Electronic Cigarettes and IQOS®.

2019

The use of novel tobacco products, particularly the electronic cigarette (EC) and partial tobacco combustion devices (HnB systems: Heat not Burn), has increased exponentially, particularly among adolescents and young people. The health authorities and scientific societies have shown concern about issues surrounding safety and effectiveness (as a method of smoking cessation). A study of the available scientific evidence has concluded that the safety of the vapor or fumes inhaled by the users of these devices cannot be guaranteed. Contradictory results from various clinical trials and meta-analyses also mean that these devices cannot be recommended for their effectiveness in cessation, especi…

medicine.medical_specialtymedicine.medical_treatmentRespiratory SystemElectronic Nicotine Delivery Systemslaw.inventionScientific evidence03 medical and health scienceschemistry.chemical_compound0302 clinical medicinelawInternal medicineNeoplasmsmedicinePulmonary MedicineHumansVareniclineSocieties MedicalBupropionAerosolsbusiness.industryThoracic SurgeryGeneral MedicineNicotine replacement therapyTobacco Use Cessation DevicesClinical trialPulmonology030228 respiratory systemchemistryCardiovascular DiseasesSpainFamily medicineSmoking cessationSmoking CessationbusinessElectronic cigarettemedicine.drugArchivos de bronconeumologia
researchProduct

Inhaled amikacin versus placebo to prevent ventilator-associated pneumonia: the AMIKINHAL double-blind multicentre randomised controlled trial protoc…

2021

IntroductionPre-emptive inhaled antibiotics may be effective to reduce the occurrence of ventilator-associated pneumonia among critically ill patients. Meta-analysis of small sample size trials showed a favourable signal. Inhaled antibiotics are associated with a reduced emergence of antibiotic resistant bacteria. The aim of this trial is to evaluate the benefit of a 3-day course of inhaled antibiotics among patients undergoing invasive mechanical ventilation for more than 3 days on the occurrence of ventilator-associated pneumonia.Methods and analysisAcademic, investigator-initiated, parallel two group arms, double-blind, multicentre superiority randomised controlled trial. Patients invasi…

medicine.medical_specialtymedicine.medical_treatmentinfectious diseasesPlacebolaw.inventionrespiratory infections03 medical and health sciences0302 clinical medicineDouble-Blind MethodRandomized controlled trialInformed consentlawAdministration InhalationmedicineHumansMulticenter Studies as Topic1506Amikacinadult intensive & critical care1707Randomized Controlled Trials as TopicMechanical ventilationclinical trials[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologybusiness.industryIntensive CareRVentilator-associated pneumoniaPneumonia Ventilator-Associated030208 emergency & critical care medicineGeneral Medicinemedicine.diseaseRespiration Artificial3. Good healthClinical trialPneumoniaTreatment Outcome030228 respiratory systemAmikacinEmergency medicineMedicinebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologymedicine.drugBMJ Open
researchProduct

Intensity of Respiratory Cortical Arousals Is a Distinct Pathophysiologic Feature and Is Associated with Disease Severity in Obstructive Sleep Apnea …

2021

Background: We investigated whether the number, duration and intensity of respiratory arousals (RA) on C3-electroencephalographic (EEG) recordings correlate with polysomnography (PSG)-related disease severity in obstructive sleep apnea (OSA) patients. We also investigated if every patient might have an individual RA microstructure pattern, independent from OSA-severity. Methods: PSG recordings of 20 OSA patients (9 female

medicine.medical_specialtymicrostructurePolysomnographyArticleArousallcsh:RC321-57103 medical and health sciences0302 clinical medicinearousalInternal medicineRespiratory disturbance indexmedicinelcsh:Neurosciences. Biological psychiatry. NeuropsychiatrySleep Stagesmedicine.diagnostic_testbusiness.industryGeneral NeuroscienceSleep apneaApneamedicine.diseasesleep apnearespiratorysleep-disturbed breathingnervous system diseasesIntensity (physics)respiratory tract diseasesObstructive sleep apnea030228 respiratory systemCardiologymedicine.symptombusiness030217 neurology & neurosurgeryBrain Sciences
researchProduct